Actas Dermo-Sifiliográficas

Actas Dermo-Sifiliográficas

Volume 98, Issue 7, September 2007, Pages 459-465
Actas Dermo-Sifiliográficas

Documento de consenso
Propuesta de protocolo para el informe histológico del tumor primario de los pacientes con un melanoma cutáneo del Grupo de Trabajo para el Melanoma Cutáneo de la Comunidad ValencianaProtocol proposal for the histological report of the primary tumor in patients with cutaneous melanoma from the task force for cutaneous melanoma of the valencian community

https://doi.org/10.1016/S0001-7310(07)70108-4Get rights and content

Resumen

En este texto se describe una propuesta de protocolo histológico para el melanoma cutáneo realizado de forma consensuada por el Grupo de Trabajo para el Melanoma Cutáneo de la Comunidad Valenciana. En él se recoge el propio protocolo y, además, incluye la descripción de cada una de las variables propuestas que ha demostrado tener un mayor impacto en el pronóstico en los trabajos previos.

Abstract

This text compiles a histological protocol proposal for cutaneous melanoma agreed by the Task Force for Cutaneous Melanoma of the Valencian Community. It brings together the protocol itself and, in addition, includes a description of each of the proposed variables that has shown to have a greater prognostic impact in previous works.

Bibliografía (53)

  • A.J. Worth et al.

    Pathologic prognostic factors for cutaneous malignant melanoma: the Western Canada Melanoma Study

    Int J Cancer

    (1989)
  • R.L. Barnhill et al.

    Predicting five-year outcome for patients with cutaneous melanoma in a population-based study

    Cancer

    (1996)
  • H. Ostmeier et al.

    Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma?

    Cancer

    (1999)
  • C.M. Balch et al.

    Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

    J Clin Oncol

    (2001)
  • M. Thorn et al.

    Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden

    J Natl Cancer Inst

    (1994)
  • A. Masback et al.

    Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review

    Melanoma Res

    (2001)
  • B.J. Averbook et al.

    A long-term analysis of 1,018 patients with melanoma by classic Cox regression and tree-structured survival analysis at a major referral center: Implications on the future of cancer staging

    Surgery

    (2002)
  • F. Levi et al.

    Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland

    Int J Cancer

    (1998)
  • R.M. MacKie et al.

    Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation

    Br J Cancer

    (1995)
  • C.M. Balch et al.

    A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma

    Surgery

    (1979)
  • A. Barth et al.

    Prognostic factors in 1,521 melanoma patients with distant metastases

    J Am Coll Surg

    (1995)
  • M.S. Blois et al.

    Malignant melanoma of the skin. I. The association of tumor depth and type, and patient sex, age, and site with survival

    Cancer

    (1983)
  • C.G. Clemente et al.

    Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

    Cancer

    (1996)
  • C.L. Day et al.

    Malignant melanoma. Prognostic significance of «microscopic satellites» in the reticular dermis and subcutaneous fat

    Ann Surg

    (1981)
  • K.T. Drzewiecki et al.

    Malignant melanoma. Changing trends in factors influencing metastasis-free survival from 1964 to 1982

    Cancer

    (1990)
  • D. Elder

    Tumor progression, early diagnosis and prognosis of melanoma

    Acta Oncol

    (1999)
  • Cited by (7)

    • Sleep-Disordered Breathing Is Independently Associated With Increased Aggressiveness of Cutaneous Melanoma: A Multicenter Observational Study in 443 Patients

      2018, Chest
      Citation Excerpt :

      Every participant completed a standardized protocol including cardiovascular and respiratory history and self-reported symptoms (witnessed apneas, chronic snoring, presence of daytime hypersomnia, sleep duration, and presence of insomnia). The following data were also recorded with respect to the melanoma: the histologic type (superficial spreading, nodular, lentigo maligna, acral lentiginous, or others/unspecified); tumoral thickness (Breslow index, in mm); the histologic presence of ulceration, regression, and the mitotic index (number of mitoses per mm2)17; and tumoral stage in accordance with the 7th edition of the staging classification system of the American Joint Committee on Cancer.18 The tumor was subsequently categorized as localized, locoregional, or distant.

    • Sentinel lymph node status in melanoma: Prognostic value in a tertiary hospital and correlation with mitotic activity

      2014, Actas Dermo-Sifiliograficas
      Citation Excerpt :

      Regression was considered to be present when an inflammatory infiltrate was observed in over 50% of the lesion, with accompanying fibrosis (even if this was less prominent). The dermatopathologist systematically recorded the following information: diagnosis, tumor thickness (Breslow thickness in mm), presence of ulceration, mitotic rate, margin involvement, depth of invasion (Clark level),7 histologic subtype, presence of regression, T stage, and presence of vertical growth.13 SLN biopsy was performed following the preoperative intradermal injection of the radionuclide technetium 99 (Nancol, Molypharma, S.A.) in the peritumoral area on the day of the procedure, with detection by a gamma camera and subsequent gamma probe examination (Navigator GPS, Dynasil Corp.).

    • Epidermal effacement in malignant melanoma

      2011, Actas Dermo-Sifiliograficas
    • Multiple primary melanoma

      2009, Actas Dermo-Sifiliograficas
    View all citing articles on Scopus
    View full text